NEW YORK and PETACH TIKVAH, Israel, May 30, 2018 /PRNewswire/ — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that the Company will present a corporate overview at the BIO International Convention, taking place June
BrainStorm Cell Therapeutics to Provide Corporate Update at the BIO International Convention
